Naftin is a Topical Cream in the Human Prescription Drug category. It is labeled and distributed by Merz Pharmaceuticals, Llc. The primary component is Naftifine Hydrochloride.
Product ID | 0259-4126_00829a7d-d654-41d1-a4cd-fd61dd93c1fb |
NDC | 0259-4126 |
Product Type | Human Prescription Drug |
Proprietary Name | Naftin |
Generic Name | Naftifine Hydrochloride |
Dosage Form | Cream |
Route of Administration | TOPICAL |
Marketing Start Date | 1998-06-01 |
Marketing Category | NDA / NDA |
Application Number | NDA019599 |
Labeler Name | Merz Pharmaceuticals, LLC |
Substance Name | NAFTIFINE HYDROCHLORIDE |
Active Ingredient Strength | 10 mg/g |
Pharm Classes | Allylamine [CS],Allylamine Antifungal [EPC] |
NDC Exclude Flag | N |
Listing Certified Through | 2019-12-31 |
Marketing Start Date | 1998-06-01 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA019599 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 1998-06-01 |
Marketing End Date | 2013-05-06 |
Marketing Category | NDA |
Application Number | NDA019599 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | GM |
Marketing Start Date | 1998-06-01 |
Marketing End Date | 2013-05-06 |
Marketing Category | NDA |
Application Number | NDA019599 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | GM |
Marketing Start Date | 1998-06-01 |
Inactivation Date | 2020-01-31 |
Marketing Category | NDA |
Application Number | NDA019599 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2010-01-15 |
Inactivation Date | 2020-01-31 |
Marketing Category | NDA |
Application Number | NDA019599 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | GM |
Marketing Start Date | 1998-06-01 |
Inactivation Date | 2020-01-31 |
Marketing Category | NDA |
Application Number | NDA019599 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 1998-06-01 |
Marketing End Date | 2013-05-06 |
Marketing Category | NDA |
Application Number | NDA019599 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 1998-06-01 |
Marketing End Date | 2013-05-06 |
Marketing Category | NDA |
Application Number | NDA019599 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | GM |
Marketing Start Date | 1998-06-01 |
Marketing End Date | 2013-05-06 |
Ingredient | Strength |
---|---|
NAFTIFINE HYDROCHLORIDE | 10 mg/g |
SPL SET ID: | f4b6c5d8-615c-47d6-8ad9-523c7ab146af |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI |
NDC | Brand Name | Generic Name |
---|---|---|
0259-4126 | Naftin | NAFTIFINE HYDROCHLORIDE |
54766-102 | Naftin | Naftifine Hydrochloride |
54766-770 | Naftin | NAFTIFINE HYDROCHLORIDE |
54766-772 | Naftin | Naftifine Hydrochloride |
0115-1510 | NAFTIFINE HYDROCHLORIDE | NAFTIFINE HYDROCHLORIDE |
0115-1512 | NAFTIFINE HYDROCHLORIDE | NAFTIFINE HYDROCHLORIDE |
40085-201 | Naftifine Hydrochloride | NAFTIFINE HYDROCHLORIDE |
40085-203 | Naftifine Hydrochloride | NAFTIFINE HYDROCHLORIDE |
51672-1362 | Naftifine Hydrochloride | Naftifine Hydrochloride |
51672-1368 | Naftifine Hydrochloride | Naftifine Hydrochloride |
51672-1376 | Naftifine Hydrochloride | Naftifine Hydrochloride |
70700-161 | Naftifine hydrochloride | Naftifine hydrochloride |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
NAFTIN 73706755 not registered Dead/Abandoned |
THAMES PHARMACAL CO., INC. 1988-01-21 |
NAFTIN 73589735 1412990 Live/Registered |
ALLERGAN PHARMACEUTICALS, INC. 1986-03-24 |